These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2415198)

  • 21. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
    Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
    Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine.
    Alfredsson G; Bjerkenstedt L; Edman G; Härnryd C; Oxenstierna G; Sedvall G; Wiesel FA
    Acta Psychiatr Scand Suppl; 1984; 311():49-74. PubMed ID: 6199949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of electroconvulsive therapy on CSF amine metabolites in schizophrenic patients.
    Cooper SJ; Leahey W; Green DF; King DJ
    Br J Psychiatry; 1988 Jan; 152():59-63. PubMed ID: 2458796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers.
    Jönsson EG; Bah J; Melke J; Abou Jamra R; Schumacher J; Westberg L; Ivo R; Cichon S; Propping P; Nöthen MM; Eriksson E; Sedvall GC
    BMC Psychiatry; 2004 Mar; 4():4. PubMed ID: 15102340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between abnormal brainstem auditory-evoked potentials and subnormal CSF levels of HVA and 5-HIAA in first-episode schizophrenic patients.
    Lindström LH; Wieselgren IM; Klockhoff I; Svedberg A
    Biol Psychiatry; 1990 Sep; 28(5):435-42. PubMed ID: 1698468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time course for effects of sulpiride and chlorpromazine on monoamine metabolite and prolactin levels in cerebrospinal fluid from schizophrenic patients.
    Härnryd C; Bjerkenstedt L; Gullberg B; Oxenstierna G; Sedvall G; Wiesel FA
    Acta Psychiatr Scand Suppl; 1984; 311():75-92. PubMed ID: 6199950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are monoamine metabolites in cerebrospinal fluid worth measuring?
    Potter WZ; Manji HK
    Arch Gen Psychiatry; 1993 Aug; 50(8):653-6. PubMed ID: 7688211
    [No Abstract]   [Full Text] [Related]  

  • 28. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoamine metabolites in the CSF of epileptic patients.
    Laxer KD; Sourkes TL; Fang TY; Young SN; Gauthier SG; Missala K
    Neurology; 1979 Aug; 29(8):1157-61. PubMed ID: 37460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity.
    Sedvall G; Fyrö B; Gullberg B; Nybäck H; Wiesel FA; Wode-Helgodt B
    Br J Psychiatry; 1980 Apr; 136():366-74. PubMed ID: 6155965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history.
    Lindström LH
    Psychiatry Res; 1985 Apr; 14(4):265-73. PubMed ID: 2410940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid monoamine metabolite concentrations as intermediate phenotypes between glutamate-related genes and psychosis.
    Andreou D; Söderman E; Axelsson T; Sedvall GC; Terenius L; Agartz I; Jönsson EG
    Psychiatry Res; 2015 Sep; 229(1-2):497-504. PubMed ID: 26142836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous measurement of monoamine metabolites and 5-methyltetrahydrofolate in the cerebrospinal fluid of children.
    Akiyama T; Hayashi Y; Hanaoka Y; Shibata T; Akiyama M; Nakamura K; Tsuyusaki Y; Kubota M; Yoshinaga H; Kobayashi K
    Clin Chim Acta; 2017 Feb; 465():5-10. PubMed ID: 27940130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid monoamine metabolites in childhood-onset schizophrenia.
    Jacobsen LK; Frazier JA; Malhotra AK; Karoum F; McKenna K; Gordon CT; Hamburger SD; Lenane MC; Pickar D; Potter WZ; Rapoport JL
    Am J Psychiatry; 1997 Jan; 154(1):69-74. PubMed ID: 8988961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis.
    Andersen O; Johansson BB; Svennerholm L
    Acta Neurol Scand; 1981 Apr; 63(4):247-54. PubMed ID: 6163303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine.
    Asberg M; Ringberger VA; Sjöqvist F; Thorén P; Träskman L; Tuck JR
    Clin Pharmacol Ther; 1977 Feb; 21(2):201-7. PubMed ID: 13959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
    Sjöström R; Ekstedt J; Anggård E
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):666-8. PubMed ID: 1159438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of propranolol on monoamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia.
    Scheinin M; van Kammen DP; Ninan PT; Linnoila M
    Clin Pharmacol Ther; 1984 Jul; 36(1):33-9. PubMed ID: 6203678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers.
    Andreou D; Saetre P; Kähler AK; Werge T; Andreassen OA; Agartz I; Sedvall GC; Hall H; Terenius L; Jönsson EG
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):700-4. PubMed ID: 21295953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smooth pursuit eye movements, clinical symptoms, CSF metabolites, and skin conductance habituation in schizophrenic patients.
    Bartfai A; Levander SE; Sedvall G
    Biol Psychiatry; 1983 Sep; 18(9):971-87. PubMed ID: 6196060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.